Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 165

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain

Skljarevski, V., Ossanna, M., Liu‐Seifert, H., Zhang, Q., Chappell, A., Iyengar, S., Detke, M., Backonja, M. · 2009 · European Journal of Neurology

Abstract

Background: Duloxetine has demonstrated analgesic effect in chronic pain states. This study assesses the efficacy of duloxetine in chronic low back pain (CLBP). Methods: Adult patients with non‐radicular CLBP entered this 13‐week, double‐blind, randomized study comparing duloxetine 20, 60 or 120 mg once daily with placebo. The primary measure was comparison of duloxetine 60 mg with placebo on weekly mean 24‐h average pain. Secondary measures included Roland‐Morris Disability Questionnaire (RMDQ‐24), Patient’s Global Impressions of Improvement (PGI‐I), Brief Pain Inventory (BPI), safety and tolerability. Results: Four hundred four patients were enrolled, 267 completed. No significant differences existed between any dose of duloxetine and placebo on reduction in weekly mean 24‐h average pain at end‐point. Duloxetine 60 mg was superior to placebo from weeks 3–11 in relieving pain, but not at weeks 12–13. Duloxetine 60 mg demonstrated significant improvement on PGI‐I, RMDQ‐24, BPI‐average pain and BPI‐average interference. Significantly more patients taking duloxetine 120 mg (24.1%) discontinued because of adverse events, versus placebo (8.5%). Conclusions: Duloxetine was superior to placebo on the primary objective from weeks 3–11, but superiority was not maintained at end‐point. Duloxetine was superior to placebo on many secondary measures, and was well‐tolerated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2009.02648.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 165

Metadata

Authors
Skljarevski, V., Ossanna, M., Liu‐Seifert, H., Zhang, Q., Chappell, A., Iyengar, S., Detke, M., & Backonja, M.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2009-08-07
Volume
16
Issue
9
Pages
1041-1048
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2135432810
Cited by
165
References
11
FWCI
9.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. https://app.cochat.ai/papers/10.1111/j.1468-1331.2009.02648.x
The paper
Skljarevski, V., Ossanna, M., Liu‐Seifert, H., Zhang, Q., Chappell, A., Iyengar, S., Detke, M., & Backonja, M. (2009). A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2009.02648.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.